Supriya Krishna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Supriya Krishna has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Björn K. Birdsong
Department of Fibre and Polymer Technology, KTH Royal Institute of Technology
1 shared publication - Carl Inge Edvard Smith
Karolinska Institutet
1 shared publication - Elin K. Esbjörner
Chalmers University of Technology
1 shared publication - Evren Alici
Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institute, Sweden
1 shared publication - H. Yesid Estupiñán
Department of Laboratory Medicine, Unit for Biomolecular and Cellular Medicine, Karolinska Institutet, Stockholm, Sweden
1 shared publication - Helena Escobar
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany
1 shared publication
Latest Publications
- Open Access
Advanced Peptide Nanoparticles Enable Robust and Efficient delivery of gene editors across cell types
Efficient delivery of the CRISPR/Cas9 system and its larger derivatives, base editors, and prime editors remain a significant challenge, particularly in tissue-specific stem cells and induced pluripotent stem cells (iPSCs). This study optimized a novel family of cell-penetrating peptides, hPep, to deliver gene-editing ribonucleoproteins. The hPep-based nanoparticles enable highly efficient and biocompatible delivery of Cre recombinase, Cas9, base-, and prime editors. Using base editors, robust and nearly complete genome editing was achieved in the human cells: HEK293T (96%), iPSCs (74%), and muscle stem cells (80%). This strategy opens promising avenues for ex vivo and, potentially, in vivo applications. Incorporating silica particles enhanced the system’s versatility, facilitating cargo-agnostic delivery. Notably, the nanoparticles can be synthesized quickly on a benchtop and stored as lyophilized powder without compromising functionality. This represents a significant advancement in the feasibility and scalability of gene-editing delivery technologies.
Open AccessAdvanced Peptide Nanoparticles Enable Robust and Efficient delivery of gene editors across cell types
Efficient delivery of the CRISPR/Cas9 system and its larger derivatives, base editors, and prime editors remain a significant challenge, particularly in tissue-specific stem cells and induced pluripotent stem cells (iPSCs). This study optimized a novel family of cell-penetrating peptides, hPep, to deliver gene-editing ribonucleoproteins. The hPep-based nanoparticles enable highly efficient and biocompatible delivery of Cre recombinase, Cas9, base-, and prime editors. Using base editors, robust and nearly complete genome editing was achieved in the human cells: HEK293T (96%), iPSCs (74%), and muscle stem cells (80%). This strategy opens promising avenues for ex vivo and, potentially, in vivo applications. Incorporating silica particles enhanced the system’s versatility, facilitating cargo-agnostic delivery. Notably, the nanoparticles can be synthesized quickly on a benchtop and stored as lyophilized powder without compromising functionality. This represents a significant advancement in the feasibility and scalability of gene-editing delivery technologies.